Telepsychiatry has transformed psychiatric and mental health care. It has improved access, reduced travel barriers, and made it easier for many patients to receive consistent, high-quality support.
At Elessar Psychiatry, telehealth is an important part of how we expand access to care in Utah and Colorado. We can meet you from the comfort of your home, and we love that!
But there are times when seeing someone face-to-face allows for a more complete clinical picture. Knowing when to shift to in-person care is not simply about preference — it is about safety, clarity, and individualized psychiatric treatment. Of course, we are always happy to meet you in person.
When We Recommend an In-Person Psychiatric Visit
While many conditions are effectively managed through telepsychiatry, certain situations benefit from being physically present in the room together. Let’s take a look…
Higher Acuity or Safety Concerns
When depression worsens, suicidal thoughts intensify, mania escalates, or psychosis emerges, in-person psychiatric visits allow for closer observation, stronger containment, and more confident safety planning. When appropriate, we may also encourage trusted members of your support system to attend in-person visits. We love meeting family members who can provider collateral information and support you,
Complex or Higher-Risk Psychiatric Medication Management
Some psychiatric medications require more nuanced monitoring, particularly during initiation or dose adjustments. For example:
- Stimulants (such as methylphenidate or amphetamine-based ADHD medications) may require in-person monitoring of blood pressure, heart rate, and weight.
- Antipsychotics may require assessment for extrapyramidal symptoms, metabolic changes, sedation, or emerging movement abnormalities.
- Certain mood stabilizers require laboratory monitoring and closer clinical follow-up.
While much of this coordination can occur remotely, there are times when direct observation improves safety and diagnostic accuracy.
Diagnostic Uncertainty
When a psychiatric diagnosis is unclear the subtle motor changes, affect shifts, psychomotor slowing, agitation, or cognitive patterns may be easier to assess in person.
Body language, eye contact, gait, posture, tremors, and overall physical presence provide meaningful diagnostic information. These details are sometimes flattened on video.
In psychiatry, small observations can guide important clinical decisions.
What the Evidence Says About Telepsychiatry
Telepsychiatry is strongly supported by research and endorsed by major psychiatric and medical organizations, including the American Psychiatric Association, the U.S. Department of Veterans Affairs, and the Centers for Medicare & Medicaid Services (CMS), as an effective treatment modality for many psychiatric conditions.
However, professional guidelines emphasize that clinicians should use clinical judgment in determining when in-person psychiatric care is appropriate — particularly when risk increases, medical monitoring is required, or a physical assessment may meaningfully influence decision-making.
Telehealth is powerful — and clinical judgment remains central to safe psychiatric care.
Telehealth Prescribing Regulations for ADHD Stimulants and Controlled Substances
Some psychiatric medications — including ADHD stimulants and certain medications for anxiety or sleep — are classified as controlled substances.
Federal law governing telehealth prescribing of controlled substances is shaped by the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which generally requires an in-person medical evaluation before prescribing controlled substances. During the COVID-19 public health emergency, temporary federal flexibilities allowed telehealth prescribing without an initial in-person visit. These flexibilities have been extended temporarily and remain subject to evolving federal rulemaking.
As regulations continue to develop, future federal guidance may clarify or modify requirements, including:
- An initial in-person evaluation prior to prescribing certain controlled substances
- Periodic in-person visits (for example, every 6–12 months)
- Additional documentation or monitoring standards
Our hybrid psychiatric practice allows us to provide in-person care in both Utah and Colorado when clinically or legally appropriate.
At Elessar Psychiatry, we actively monitor updates from the Drug Enforcement Administration (DEA), state licensing boards, and professional organizations to ensure our telehealth prescribing practices remain compliant and aligned with best-practice standards.
In addition, we routinely review Prescription Drug Monitoring Programs (PDMPs) as part of responsible controlled substance prescribing. Prescription Drug Monitoring Programs are secure, state-run databases used to monitor controlled substance prescriptions and help clinicians identify potential interactions, duplications, or safety concerns.
If an in-person psychiatric visit is required — whether for regulatory reasons or clinical best practice — we communicate clearly and plan proactively. Our hybrid model is intentionally structured to support both accessibility and regulatory readiness.
The priority is not convenience alone. The priority is safe, ethical, individualized psychiatric care to help you achieve your goals.
A Reassuring Takeaway
If your provider recommends an in-person psychiatric visit, it is not a setback.
It does not mean you are “worse.”
It does not mean telehealth failed.
It reflects thoughtful, individualized care and a commitment to your safety.
Hybrid psychiatry is not about choosing convenience over quality. It is about matching the right setting to the right moment in treatment.
Our hybrid psychiatric practice serves patients throughout Utah and Colorado, offering both telehealth psychiatry and in-person psychiatric visits when clinically appropriate.
No matter how or where we see you, we are honored that you trust us with your care.
Katy Alderman, MSN, APRN, PMHNP-BC
Founder, Elessar Psychiatry
Serving Utah & Colorado | Hybrid Telehealth & In-Person Psychiatry
References
American Psychiatric Association. (2020). Telepsychiatry toolkit and guidance. American Psychiatric Association. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry
Ryan Haight Online Pharmacy Consumer Protection Act of 2008, 21 U.S.C. § 829(e).
U.S. Drug Enforcement Administration. (2023). Telemedicine prescribing of controlled substances proposed rule. U.S. Department of Justice.
Shore, J. H., Yellowlees, P., Caudill, R., et al. (2018). Best practices in videoconferencing-based telemental health. Telemedicine and e-Health, 24(11), 827–832.